Dr. Ephraim Fuchs is a Professor of Oncology and Immunology at Johns Hopkins University and a world-renowned bone marrow transplant physician and researcher. Among his many innovations, he conceived and performed the first cyclophosphamide procedure in the field of Bone Marrow transplant, which has become the standard of care in unrelated bone marrow transplant. This […]
Timothy Wan, Esq., is the NKR’s General Counsel and Chief Litigator. He oversees contracts, leases, intellectual property, employment law, risk management and litigation. Mr. Wan was admitted to the New York State Bar in January 2001, after graduating from Brooklyn Law School with his Juris Doctor, and from Vassar College, with a double B.A. in […]
Jon Sullenberger is a living kidney donor and leads the NKR’s donor and patient advocacy teams. His first contact with the NKR was in 2019, when he enrolled in the Voucher Program to get his wife off dialysis. During this difficult and challenging process, he identified significant opportunities for improvement and presented his ideas to […]
Frank Schultz leads the NKR Software Development team, the Quality Assurance team, and the Information Technology group. He is responsible for technical leadership, software processes, and the execution of development projects. With over two decades of software experience and more than 10 years in the life sciences industry, Mr. Schultz has held executive roles at […]
Samantha Hil is a kidney transplant recipient and the catalyst for the formation of the NKR and ImmunoFree. She manages the microsite product, leads the teams that design and manage all of the NKR’s websites, and is the organization’s chief editor, responsible for writing and reviewing the company’s published material, both online and in print. […]
Before joining the NKR as Chief Operating Officer and Chief Financial Officer, Ryan Meehan co-founded and served as the Chief Executive Officer of Cell Tolerance, Inc. (CTI), an early-stage biotechnology company focused on developing a cellular therapy to induce immunological tolerance in haploidentical sibling transplants. In 2023, Ryan transitioned to the NKR full-time while also […]
Dr. Matthew Cooper is the Chief of Transplantation, Director of Solid Organ Transplantation, and a tenured Professor of Surgery at the Medical College of Wisconsin. He is the Mark B. Adams Distinguished Professor of Surgery and a member of the National Kidney Registry’s Medical Board and its Surgical Director. Dr. Cooper chose the specialty of […]
Garet Hil is the Founder and Chief Executive Officer of the National Kidney Registry (NKR) and ImmunoFree. Mr. Hil became involved in transplant medicine when his daughter was diagnosed with kidney failure at age 10. After he and his wife were both deemed incompatible, a difficult and extensive donor search finally resulted in a successful […]
